MIAMI--(BUSINESS WIRE)--OPKO Health, Inc. (NYSE:OPK) announced today that the American Medical Association (AMA) Current Procedural Terminology (CPT®) Editorial Panel has granted a Category I CPT code ...
MIAMI, Nov. 15, 2019 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (OPK) today announced that Novitas Solutions, Inc. has issued its final Local Coverage Determination (LCD) for Medicare payments for the ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
The 4Kscore test has been adopted into NCCN guidelines and impacts physician and patient decisions while reducing healthcare costs. OPKO had not submitted complete dossiers to either Novitas or ...
OPKO introduces 4Kscore Test, a blood test to identify risk for aggressive prostate cancer in Europe
OPKO Health, Inc., a multinational biopharmaceutical and diagnostics company, has announced the European launch of the 4Kscore Test, the only blood test that accurately identifies risk for aggressive ...
“We were now interested to understand whether a 4Kscore test in pretreatment blood could improve assessment of risk of adverse pathology features above and beyond the established predictors, such as ...
The cash register is ringing at OPKO Health (OPK), which spells great news for investors. Last week, OPKO announced that its 4Kscore test for the detection of prostate cancer has been granted a Level ...
MIAMI, May 18, 2017 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ:OPK), announces that data from a prospective study conducted at Veteran Affairs (VA) hospitals confirming the 4Kscore test’s ability ...
ORLANDO, Florida — A newly available commercial blood test performs better than a commonly used online risk calculator in predicting which men with an elevated prostate-specific antigen (PSA) level ...
MIAMI, June 28, 2019 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) today announced that Novitas Solutions, Inc. has issued a new proposed local coverage determination (LCD) for the 4Kscore® test ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results